Literature DB >> 19040786

IL-6 release by LPS-stimulated peripheral blood mononuclear cells as a potential biomarker in Alzheimer's disease.

Adam Kaplin, Katherine A L Carroll, Jenn Cheng, Rameeza Allie, Constantine G Lyketsos, Peter Calabresi, Paul B Rosenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19040786      PMCID： PMC2664968          DOI： 10.1017/S1041610208008107

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN： 1041-6102            Impact factor:   3.878


× No keyword cloud information.
  13 in total

1.  Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines.

Authors:  Marcella Reale; Carla Iarlori; Francesco Gambi; Claudio Feliciani; Anatolia Salone; Lucia Toma; Giovanna DeLuca; Mirella Salvatore; Pio Conti; Domenico Gambi
Journal:  J Neuroimmunol       Date:  2004-03       Impact factor: 3.478

2.  Cytokines, p38 MAP kinase and the pathophysiology of depression.

Authors:  Andrew H Miller; Charles L Raison
Journal:  Neuropsychopharmacology       Date:  2006-10       Impact factor: 7.853

3.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

4.  Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6.

Authors:  Luc Vallières; Iain L Campbell; Fred H Gage; Paul E Sawchenko
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

Review 5.  Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease.

Authors:  J Rogers; L F Lue
Journal:  Neurochem Int       Date:  2001 Nov-Dec       Impact factor: 3.921

Review 6.  Immunological aspects of microglia: relevance to Alzheimer's disease.

Authors:  E N Benveniste; V T Nguyen; G M O'Keefe
Journal:  Neurochem Int       Date:  2001 Nov-Dec       Impact factor: 3.921

7.  Research consent for cognitively impaired adults: recommendations for institutional review boards and investigators.

Authors: 
Journal:  Alzheimer Dis Assoc Disord       Date:  2004 Jul-Sep       Impact factor: 2.703

8.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

9.  Interleukin 1 beta inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus.

Authors:  F P Bellinger; S Madamba; G R Siggins
Journal:  Brain Res       Date:  1993-11-19       Impact factor: 3.252

Review 10.  Visualising microglial activation in vivo.

Authors:  Richard B Banati
Journal:  Glia       Date:  2002-11       Impact factor: 8.073
View more
  8 in total

1.  Prediction of S-glutathionylated proteins progression in Alzheimer's transgenic mouse model using principle component analysis.

Authors:  Cheng Zhang; Ching-Chang Kuo; Alan W L Chiu; June Feng
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 2.  Biomarkers for Alzheimer's disease: ready for the next step.

Authors:  Paul B Rosenberg; Argye E Hillis
Journal:  Brain       Date:  2009-07-16       Impact factor: 13.501

3.  CCR6: a biomarker for Alzheimer's-like disease in a triple transgenic mouse model.

Authors:  Sandhya Subramanian; Patricia Ayala; Teri L Wadsworth; Christopher J Harris; Arthur A Vandenbark; Joseph F Quinn; Halina Offner
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

4.  Amyloid Beta Peptide (Aβ1-42) Reverses the Cholinergic Control of Monocytic IL-1β Release.

Authors:  Katrin Richter; Raymond Ogiemwonyi-Schaefer; Sigrid Wilker; Anna I Chaveiro; Alisa Agné; Matthias Hecker; Martin Reichert; Anca-Laura Amati; Klaus-Dieter Schlüter; Ivan Manzini; Günther Schmalzing; J Michael McIntosh; Winfried Padberg; Veronika Grau; Andreas Hecker
Journal:  J Clin Med       Date:  2020-09-07       Impact factor: 4.241

5.  Identifying early inflammatory changes in monocyte-derived macrophages from a population with IQ-discrepant episodic memory.

Authors:  Eric J Downer; Raasay S Jones; Claire L McDonald; Eleonora Greco; Sabina Brennan; Thomas J Connor; Ian H Robertson; Marina A Lynch
Journal:  PLoS One       Date:  2013-05-06       Impact factor: 3.240

6.  Modulation of TLR3/TLR4 inflammatory signaling by the GABAB receptor agonist baclofen in glia and immune cells: relevance to therapeutic effects in multiple sclerosis.

Authors:  Tadhg Crowley; John-Mark Fitzpatrick; Teun Kuijper; John F Cryan; Orna O'Toole; Olivia F O'Leary; Eric J Downer
Journal:  Front Cell Neurosci       Date:  2015-07-28       Impact factor: 5.505

7.  Proinflammatory profile of in vitro monocytes in the ageing is affected by lymphocytes presence.

Authors:  Karen Henriette Pinke; Bruno Calzavara; Patricia Freitas Faria; Magda Paula Pereira do Nascimento; James Venturini; Vanessa Soares Lara
Journal:  Immun Ageing       Date:  2013-06-08       Impact factor: 6.400

8.  Poor Diet, Long Sleep, and Lack of Physical Activity Are Associated with Inflammation among Non-Demented Community-Dwelling Elderly.

Authors:  Maria Basta; Christina Belogianni; Mary Yannakoulia; Ioannis Zaganas; Symeon Panagiotakis; Panagiotis Simos; Alexandros N Vgontzas
Journal:  Healthcare (Basel)       Date:  2022-01-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.